Skip to content

ERC Pharma: what changed

BE 1002.131.150NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€179,975
2024 · -€151,962-€28,013
Equity
-€231,937
2024 · -€51,962-€179,975
Cash
-
2024 · €36-€36
Balance sheet total
€3.6m
2024 · €3.7m-€141,002

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€125,898

    down €125,898 (-27.4%), from €458,970 to €333,072

Equity and liabilities
  • Debts after one year -€332,685

    down €332,685 (-16.5%), from €2.0m to €1.7m

  • Profit (loss) carried forward -€179,975

    down €179,975 (-118%), from -€151,962 to -€331,937

  • Current portion of long-term debt +€165,909

    up €165,909 (+83.7%), from €198,111 to €364,020

  • Other debts +€99,253

    up €99,253 (+6.4%), from €1.5m to €1.6m

  • Trade debts +€97,617

    up €97,617 (+8,944%), from €1,091 to €98,708

Income statement
  • Financial charges +€23,081

    up €23,081 (+27.8%), from €83,131 to €106,212

  • Gross operating margin -€11,429

    down €11,429 (-23.2%), from -€49,253 to -€60,682

  • Depreciation -€6,743

    down €6,743 (-30.9%), from €21,812 to €15,069

  • Other operating charges +€3,262

    up €3,262 (+3,262%), from €100 to €3,362

  • Financial income +€3,016

    up €3,016 (+129%), from €2,334 to €5,350

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 -€151,962
Gross operating margin -€11,429
Depreciation +€6,743
Other operating charges -€3,262
Financial income +€3,016
Financial charges -€23,081
Result 2025 -€179,975
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€161,209
Investment €0
Financing -€161,245
Cash 2024 €36
Net result for the year -€179,975
Depreciation +€15,069
Receivables within one year +€125,898
Trade debts +€97,617
Tax, wage and social debts +€3,348
Other debts +€99,253
Debts after one year -€332,685
Current portion of long-term debt +€165,909
Short-term financial debts +€5,531
Cash 2025 €0
brings cash intakes cash out
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €3,699,179 €3,558,176 -€141,002 -3.8%
Formation expenses 20 €1,570 €1,177 -€392 -25.0%
Fixed assets 21/28 €3,238,604 €3,223,927 -€14,677 -0.5%
Tangible fixed assets 22/27 €590,104 €575,427 -€14,677 -2.5%
Land and buildings 22 €590,104 €575,427 -€14,677 -2.5%
Financial fixed assets 28 €2,648,500 €2,648,500 = 0.0%
Current assets 29/58 €459,005 €333,072 -€125,933 -27.4%
Amounts receivable within one year 40/41 €458,970 €333,072 -€125,898 -27.4%
Other amounts receivable 41 €458,970 €333,072 -€125,898 -27.4%
Cash at bank and in hand 54/58 €36 - -€36
Total equity and liabilities 10/49 €3,699,179 €3,558,176 -€141,002 -3.8%
Equity 10/15 -€51,962 -€231,937 -€179,975 -346%
Contributions 10/11 €100,000 €100,000 = 0.0%
Capital 10 - €100,000 +€100,000
Issued capital 100 - €100,000 +€100,000
Contributions outside capital 11 €100,000 - -€100,000
Other 1109/19 €100,000 - -€100,000
Profit (loss) carried forward 14 -€151,962 -€331,937 -€179,975 -118%
Amounts payable 17/49 €3,751,141 €3,790,114 +€38,973 +1.0%
Amounts payable after more than one year 17 €2,012,678 €1,679,994 -€332,685 -16.5%
Financial debts 170/4 €2,012,678 €1,679,994 -€332,685 -16.5%
Amounts payable within one year 42/48 €1,738,462 €2,110,120 +€371,658 +21.4%
Current portion of amounts payable after more than one year 42 €198,111 €364,020 +€165,909 +83.7%
Financial debts 43 - €5,531 +€5,531
Credit institutions 430/8 - €5,531 +€5,531
Trade debts 44 €1,091 €98,708 +€97,617 +8,944%
Suppliers 440/4 €1,091 €98,708 +€97,617 +8,944%
Taxes, remuneration and social security 45 - €3,348 +€3,348
Taxes 450/3 - €3,348 +€3,348
Other amounts payable 47/48 €1,539,260 €1,638,512 +€99,253 +6.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €21,812 €15,069 -€6,743 -30.9%
Other operating charges 640/8 €100 €3,362 +€3,262 +3,262%
Gross operating margin 9900 -€49,253 -€60,682 -€11,429 -23.2%
Operating profit (loss) 9901 -€71,165 -€79,113 -€7,948 -11.2%
Financial income 75/76B €2,334 €5,350 +€3,016 +129%
Recurring financial income 75 €2,334 €5,350 +€3,016 +129%
Financial charges 65/66B €83,131 €106,212 +€23,081 +27.8%
Recurring financial charges 65 €83,131 €106,212 +€23,081 +27.8%
Profit (loss) for the period before taxes 9903 -€151,962 -€179,975 -€28,013 -18.4%
Profit (loss) for the period 9904 -€151,962 -€179,975 -€28,013 -18.4%
Profit (loss) for the period to be appropriated 9905 -€151,962 -€179,975 -€28,013 -18.4%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

The filed figures and these assumptions give no positive value. The adjusted equity and the average result are both zero or negative.

Part of the calculation comes out below zero. A shareholding is never worth less than zero, so the floor is zero.

Adjusted equity -€233,114

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
-€231,937
Formation expenses (20)
-€1,177
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
-€233,114

Capitalised earnings

net result for the year (9904)
2025
-€179,975
2024
-€151,962
Average result
-€165,969
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 21 November 2026 via checked.be.